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CHAPTER 1:  HYPOTHESIS, SPECIFIC AIMS & INTRODUCTION 
 
Soy isoflavones are natural compounds extracted from soybeans and have 
demonstrated chemoprotective effects and anti-cancer properties (1).  In addition, Dr. 
Hillman’s lab has recently shown that soy isoflavones act as radioprotectants of normal 
lung tissues when given in conjunction with radiation therapy.  In a mouse model of lung 
tumors and in naïve mice, soy isoflavones reduced the extent of pneumonitis and 
fibrosis caused by radiation damage to lung tissue (2,3,4).    
Hypothesis:  Based on previous studies showing mitigation of radiation-induced 
pneumonitis and fibrosis by soy isoflavones, we hypothesized that soy isoflavones could 
provide radioprotection of normal esophageal tissues from radiation-induced tissue 
damage. To address this hypothesis, we have examined esophageal tissues from naïve 
mice treated with radiation and soy isoflavones using histological and 
immunohistochemistry methods.    
The specific aims of my research project were:   
1) To characterize the histopathological changes of radiation-induced damage in 
esophagus.  
2) To investigate the effect of soy isoflavones on reducing tissue damage in esophagus. 
Clinical Significance:  Prevalence and Clinical Presentation of Radiation 
Esophagitis 
     Radiation-induced toxicity to normal esophageal tissue is a dose-limiting side effect 
of radiotherapy for cancers of the thorax as well as head and neck.  Based on Alevronta 
et al., the esophagus has dose-dependent levels of toxicity (5), and this involves tissue 
responses to different radiation strategies – single high dose, hyperfractionated, and 
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hypofractionated.  Additionally, radiation toxicity in the esophagus can be exacerbated 
by the addition of one or more chemotherapeutic drugs to the radiation treatment. (6).  
In a clinical report conducted by Werner-Wasik et al. (7), radiation esophagitis is a 
highly common ailment experienced by most patients undergoing cancer therapy.  
Werner-Wasik identified that 33% of non-small cell lung cancer patients (NSCLC) 
receiving chemoradiation developed grade 3 or higher radiation esophagitis, but 95% of 
patients developed some level of radiation esophagitis (grade 1-4) (7) (see table 1 
below).  
 
Table 1. RTOG Grading Scale with Esophagus Radiation Toxicity & Werner-Wasik 
Study Results 
RTOG 
Grade 
Associated Clinical Symptoms of 
Radiation Esophagitis 
From Werner-Wasik Study:        
 % of Total Patients 
Experiencing Symptoms* 
Grade 1 mild dysphagia or odynophagia/may 
require topical anesthetic or non-narcotic 
analgesic/may require soft diet 
20% 
Grade 2 moderate dysphagia/odynophagia/may 
require narcotic analgesics/may require 
puree or liquid diet 
41% 
Grade 3 severe dysphagia/odynophagia with 
dehydration or weight loss (more than 
15% from pretreatment baseline) 
requiring N-G feeding tube, i.v. fluids or 
hyperalimentation 
31% 
Grade 4 complete obstruction, ulceration, 
perforation, fistula 
2% 
*Findings from Werner-Wasik et al. study found only 5% of patients did not experience any level of 
radiation esophagitis (7). 
As described in Table 1., radiation-induced esophagitis presents with acute and/or 
chronic clinical symptoms, which include odynophagia (irritation and burning sensation 
upon swallowing) and dysphagia (difficulties in the function of swallowing).   
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     Odynophagia symptoms usually have a rapid onset, and can ultimately be dose-
limiting, presenting a serious challenge for radiation oncologists to follow through with 
radiation regimens and commonly results in ‘premature’ (early) termination of radiation 
treatment (7,18). Odynophagia can be attributed to one or many of the following 
histological changes from radiation insult: rapid mucosal epithelium depletion, limited 
basal cell proliferation for epithelial repopulation, and tissue ulceration. (8,9,10,11) 
     Alternatively, dysphagia results from an acute or chronic tissue response to radiation 
injury and produces a mechanical restriction (and subsequent discomfort) in the action 
of swallowing.  First, in an early response to radiation as seen in many tissues, the 
esophagus undergoes extensive tissue edema, which is a hallmark of radiation induced 
tissue damage (8,9,12,20,21).  Radiation produces a cyclic, chronic inflammatory 
response, which includes the deposition of collagen and reconstitution of extracellular 
matrix compartments (13). Accumulation of collagen and extracellular matrix 
components over a long period of time explains long-term development of esophageal 
strictures, an ailment that emerges months to years after radiation treatment (5,6,8,13).  
Ultimately, whether it’s sudden tissue swelling from an edematous response, or late-
forming regions of inappropriate collagen deposition within submucosal tissue layers, 
radiation-induced tissue damage has multiple events contributing to dysphagia, and 
limiting the esophagus’s essential role as an organ.  
     In summary, esophagitis is an early side effect of radiation or chemoradiation, 
causing pain, difficulties in swallowing and eating, and dehydration, and in the chronic 
phase, strictures may develop. These symptoms could lead to early interruption of 
radiation treatment, limiting the efficacy of radiation therapy.   Therefore, it is imperative 
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to design strategies to alleviate the clinical symptoms of radiation-induced toxicity to the 
normal esophagus.  
Soy Mitigates Radiation Injury to Normal Lung 
     Our lab has observed the effect of soy isoflavones to act as an anticancer agent and 
enhance radiation-induced cancer cell killing in studies in vitro and in vivo in tumor 
models of prostate cancer, renal cancer, and lung cancer (14,15,16).  In addition to 
radiosensitizing tumor cells, studies in lung tumor models demonstrated that soy 
isoflavones mitigate radiation-induced pneumonitis and fibrosis in normal lung tissue. 
This differential effect of soy isoflavones on cancer cells versus normal tissue was 
shown in an orthotopic murine model of lung cancer, which involves soy increasing 
radiation-induced destruction of lung tumor nodules while mitigating vascular damage, 
inflammation, and fibrosis caused by radiation in normal lung tissue. (2,3).   
     To further investigate the radioprotective effects of soy isoflavones on lungs from 
naïve mice, thoracic irradiation at high doses of 10 Gy or 12 Gy administered alone or in 
combination with soy isoflavones, given prior and after irradiation, protected the lungs 
against adverse effects of radiation.  Soy isoflavones provided many radioprotective 
effects, including reduced hair loss, restored respiratory function (breathing rates 
comparable to control), reduced pneumonitis (i.e. thickening of alveolar septa), 
decreased inflammatory infiltrates, and decreased lung fibrosis (4).  These findings 
within normal lung tissue are indicative of early and late effects of radiation-induced 
tissue injury and subsequent inflammatory response, and support a radioprotective role 
for soy isoflavones in the context of pneumonitis and pulmonary fibrosis, and potentially 
in overall radiation-induced toxicity.  
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     The radiation damage and inflammatory response seen in these lung studies is one 
example of the radiation-induced tissue injury and associated organ dysfunction, either 
as sudden thickening of alveolar septa and progressive accumulation of fibrotic collagen 
in the tissue microenvironment. However, as the lung studies have suggested, soy 
isoflavones have the capacity to affect multiple aspects of the inflammatory-mediated 
outcome to radiation injury, and could potentially play a role in alleviating tissue injury in 
other thoracic organs. 
Goals of Study and Overview of Findings 
     Given the severity of esophagitis caused by radiation in lung cancer patients, we 
have now investigated whether soy isoflavones could reduce the tissue damage in 
normal esophagus.  These studies were conducted in naïve immunocompetent mice 
(non tumor-bearing), using conditions of high-dose radiation at 10 Gy or 25 Gy to detect 
significant tissue damage, which have been shown to result in greater toxicity in clinical 
studies. (17).  Soy isoflavones were administered to mice in a controlled dose given by 
gavage prior to and after radiation for up to 4 months.  Esophageal tissues were 
obtained at different time points after radiation from untreated mice and mice treated 
with soy isoflavones alone, radiation alone, and combined radiation and soy to evaluate 
the effect of combined therapy compared to single therapy.   
     Using immunostaining techniques, we have defined the histopathological changes 
induced by radiation in multiple tissue layers of the esophagus. This included 
disruptions to the mucosal epithelium, lamina propria, muscularis mucosa and 
submucosa tissue layers.  Our studies showed that soy isoflavones reduced the extent 
of damage to the various esophageal tissue layers and confirmed a role for soy 
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isoflavones as a complementary and safe approach to improve the efficacy of 
radiotherapy for lung cancer.    
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CHAPTER 2:  MATERIALS AND METHODS 
Mice  
     Female C57BL/6 mice of 5-6 week old (Harlan, Indianapolis, IN) were housed and 
handled in animal facilities accredited by the Association for Assessment and 
Accreditation of Laboratory Animal Care (AAALAC). Animal protocol was approved by 
the Institutional Animal Care and Use Committee (IACUC). 
Soy Isoflavones 
     The soy isoflavones mixture G-4660 used is a pure extract of 98.16% isoflavones 
from soybeans consisting of 83.3% genistein, 14.6% daidzein and 0.26% glycitein 
(manufactured by Organic Technologies and obtained from NIH). The soy isoflavone 
mixture was dissolved in dimethyl sulfoxide (DMSO) and diluted 1:20 in sesame seed oil 
just prior to gavage to avoid irritation of the esophagus by DMSO. Mice were orally 
treated with soy isoflavones by gavage. Mice in the control and radiation-alone groups 
received vehicle alone.  
Thoracic Irradiation 
     Radiation was delivered at a dose of 10 Gy to the mouse thorax including 
esophagus, bilateral lungs and mediastinum. Three anesthetized mice, in jigs, were 
positioned under a 6.4 mm lead shield with 3 cut-outs in an aluminum frame mounted 
on the X-ray machine to permit selective irradiation of the lung in 3 mice at a time, as 
previously described (2,3,4). Radiation dose to the thorax and scattered dose to areas 
of the mouse outside of the radiation field were carefully monitored. To minimize 
backscattering of radiation, the bottom of the aluminum frame that holds the jigs was 
hollowed and the backplate of the jig was thinned to 1.6mm thickness. Dose to shielded 
regions was reduced to 1% of the dose in the irradiated field. Dose rate was 117.5 
	  
	   	  
	  
8	  
cGy/min and HVL was 2 mm Cu. Photon irradiation was administered using a Siemens 
Stabilipan X-ray set (Siemens Medical Systems, Inc) operating at 250 kV, 15 mA, with 1 
mm copper beam filtration at a distance of 47.5 cm from the target.  
Experimental protocol 
     Mice were pre-treated with oral soy isoflavones each day for 3 days at a dose of 
5mg/day (equivalent to 250mg/kg). On day 4, the thorax was selectively irradiated with 
a dose of 10 Gy. Soy treatment was continued on a daily basis for 5 more days at 
5mg/day. Then, mice were treated with a lower dose of 1mg/day (equivalent to 
50mg/kg), given daily 5 days a week for up to 16 weeks. The rationale for giving a 
higher dose of soy isoflavones for pre-treatment and just after radiation is to optimize 
the effect of soy based on our previous studies (3,4).  
Esophagus tissue preparation for histology  
     Mice were sacrificed at different time points between 1 to 16 weeks after irradiation.  
Esophagi were resected from the proximal end (near the pharynx) to the distal end 
(esophageal-gastric junction) within the field of radiation.  Distal ends of the esophagus 
were marked with blue dye (Davidson Marking System, Bloomington, MN) to ensure 
that sections which were irradiated were analyzed.  Resected esophagi were fixed and 
curved into a U shape for embedding in vertical position in paraffin and transverse 
tissue sections were cut.  Esophagus sections were stained with hematoxylin-eosin 
(H&E) and examined using a Nikon E-800 microscope. Morphometric measurements of 
inner esophageal tissue layers were performed using Image-ProPlus version 6.2 
software (Media-Cybernetics) (ref). The effect of radiation and soy on esophageal layers 
was evaluated using Masson Trichrome (MT) stain for detecting collagen fibers 
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(NovaUltra Kit, IHCWORLD, Woodstock, MD). Histological findings were quantified 
using a scoring system on a scale from weak (±), moderate (+), strong (++), and heavy 
(+++).   
Immunohistochemistry (a-SMA, CD45) 
     Sections of esophagi were stained by immunohistochemistry. Sections were blocked 
with IHC Tek Antibody Diluent, and then incubated with primary purified monoclonal 
antibodies directed against α-SMA (Sigma-Aldrich, St Louis, MO), CD45 (eBioscience, 
San Diego, CA) and Ki-67 (LifeSpan, Seattle, WA) overnight at 4° C. Sections were 
then incubated with biotinylated secondary antibodies (Vector Labs, Burlingame, CA) at 
1:300 for 1 hour at room temperature. Staining was amplified with the avidin-biotin 
system Vectastain ABC Reagent Kit (Vector Labs) and visualized with the Vector DAB 
Substrate Kit for peroxidase (Vector Labs). Sections were counterstained with IHC-Tek 
Mayer’s Hematoxylin (IHC World) and mounted with Permount mounting media 
(Electron Microscopy Sciences, Hatfield, PA). Esophageal layers were examined on a 
Nikon E800 microscope (Nikon Inc., Melville, NY). Histological findings were quantified 
using a scoring system on a scale from weak (±), moderate (+), strong (++), and heavy 
(+++).   
Statistical Analysis 
     For histological data, differences in the thickness of inner esophageal tissue layers 
among the various treatment groups were analyzed by two-tailed unpaired Student’s t 
test. A value of p < 0.05 was considered statistically significant and results were 
summarized as found in table 1. 
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CHAPTER 3:  RESULTS 
Soy isoflavones reduce radiation damage to esophageal layers.  
     To assess the effects of irradiation and soy isoflavones on normal esophagus, the 
esophagus was resected at 4, 10, and 16 weeks after treatment with either soy alone, 
radiation alone, or both radiation and soy isoflavones, and esophagus tissues were 
processed for histology studies.  A transverse section of the esophagus shows tissue 
layers lining the lumen and extending into the 2 skeletal muscle layers of the muscularis 
externa (inner circular layer and outer longitudinal layer)(ME, Fig. 1A).  Esophageal 
tissue layers include the mucosal epithelium (EPI), lamina propria (LP), muscularis 
mucosae (MM), submucosa (SM) lining the muscularis externa (ME) (Fig. 1B).   
     Because alterations induced by radiation were observed in LP, MM, and SM, these 
three layers were grouped as inner esophageal layer (IEL) and to evaluate the 
differences in IEL between treatment groups, morphometric measurements of IEL were 
performed (Table 2).  At all time points, esophagus from control mice showed normal 
esophageal tissue layer structure and integrity, including a healthy mucosal epithelium, 
a thin, dense and continuous LP, and small smooth muscle cells within the MM (Fig. 
1C1,2,3, Table 2).  Treatment with soy isoflavones did not show alterations in mucosal 
epithelium nor IEL, which looked normal compared to untreated esophagi (Fig. 
1D1,2,3).  In contrast, mouse esophagus treated with radiation caused significant tissue 
damage that was observed at 4, 10, and 16 weeks after radiation.  Mucosal epithelium 
showed disruption in the basal cell layer alignment (circle in Fig. 1E1).  Smooth muscle 
cells in the MM became enlarged in response to radiation (arrows in Fig. 1E2) and the 
IEL became thickened starting at 4 weeks, and increased at 10 and 16 week time points 
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(bracket in Fig. 1E3, Table 2).  Esophagus from mice treated with soy isoflavones 
before and after radiation showed minimal tissue damage with a mucosal epithelium 
and IEL comparable to that in normal esophagus (Fig. 1F1,2,3).  Soy isoflavones 
decreased IEL tissue thickening that was seen in mice treated with radiation alone (Fig. 
1F3) and differences in IEL tissue thickness were statistically significant (P<0.05) at all 
time points compared to radiation alone. (Table 2).  
Soy isoflavones reduce disruptions of lamina propria connective tissues caused 
by radiation.  
     Previous studies in our lab showed that soy isoflavones decrease the pulmonary 
fibrosis induced by radiation (2,3,4).  In order to evaluate the effect of radiation and/or 
soy isoflavones on collagen fibers within the lamina propria (LP), esophagus tissue 
sections were stained with Masson’s Trichrome stain.  Esophagi from control mice 
showed a dense blue, collagen-rich, lamina propria (LP) tissue layer at all time points 
(circles in Fig. 2A1,2,3). Similar findings were shown in mice treated with soy 
isoflavones alone (circles Fig. 2B1,2,3).  Irradiated esophagus revealed that density of 
collagen fibers was reduced in the LP (circle in Fig. 2C1) and collagen fibers were seen 
infiltrating into muscularis mucosae (MM) layer (arrows in Fig. 2C2,3).  Esophagi from 
mice treated with irradiation and soy isoflavones showed increased collagen stain 
density in LP, and limited positive collagen staining within the MM.  These findings were 
comparable to that of control and soy isoflavone treated mice, predominately at 4 and 
10 weeks after radiation (Fig. 2D1,2,3, Table 3).  
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Soy isoflavones decreases smooth muscle cell destruction induced by radiation. 
     H&E staining and Masson’s Trichrome stain of esophagus tissues showed 
hypertrophy and vacuolation of smooth muscle cells in muscularis mucosae (MM).  In 
order to evaluate smooth muscle cell hypertrophy within the MM tissue layer, tissue 
sections were stained by immunohistochemistry using anti-α smooth muscle actin 
(αSMA).  Untreated esophagus showed normal dense staining of smooth muscle cells 
and an overall thin and highly integral MM at all time points (Fig. 3A1,2,3).   Findings 
were similar in mice treated with soy isoflavones (Fig. 3B1,2,3).  Esophagi from mice 
treated with radiation showed smooth muscle cells that had become hypertrophied, 
significantly increasing cell size, and cytoplasmic vacuolization at 4 weeks and persisted 
through 16 weeks (circles in Fig. 3C1, 3C3).  Additionally, irradiated esophagi showed 
fragmentation in the continuity of the densely packed smooth muscle cells within the 
MM layer at all time points (arrows in Fig. 3C2). Esophagi from mice treated with 
combined radiation and soy isoflavones showed reduced smooth muscle cell 
hypertrophy, with cell size comparable to control, and limited fragmentation of MM 
smooth muscle throughout all time points after radiation treatment (Fig. 3D1,2,3, Table 
3).     
Soy isoflavones reduce leukocytic infiltration within esophageal tissue layers 
after radiation.  
     In response to radiation-induced tissue injury, infiltration of immune cells to the site 
of injury can occur, contributing to the overall inflammatory response.  This effect has 
been well documented, including previous studies by our lab on radiation-induced lung 
injury, resulting in pneumonitis.  These studies found that supplementation of soy 
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isoflavones to radiation therapy reduced inflammatory infiltrates within the normal lungs 
(2,3,4).  In order to evaluate inflammatory infiltration induced by radiation and the effect 
of soy isoflavones, esophagus tissue sections were obtained at 4 weeks after treatment 
and stained by immunohistochemistry using the pan-leukocyte CD45 marker.  Esophagi 
from untreated mice and mice treated with soy isoflavones showed no CD45+ cells 
within tissue sections (Fig. 4A,B).  Irradiated esophagus tissues contained several focal 
areas of CD45+ cells at the edge of the mucosal epithelium lining the lamina propria 
(LP) (arrows Fig. 4C) and these clusters were found in multiple sites throughout tissue 
sections. Esophagi treated with radiation and soy isoflavones showed minimal 
infiltration of CD45+ cells (Fig. 4D). 
Soy isoflavones mitigates early effects of radiation-induced damage on the 
mucosal epithelium. 
     We have discussed the histopathological changes occurring in response to radiation, 
and mitigation by soy isoflavones at 4 to 16 weeks after radiation treatment and at a 
single dose of 10 Gy radiation. However, it known that early tissue responses to 
radiation-induced injury are highly implicated in the development of acute symptoms 
and side effects to radiation treatment (7,8,9,10,11,18).  Additionally, a single dose of 10 
Gy irradiation is not fully representative of what is used in the clinic, and a fair proportion 
of patients develop radiation-induced esophagitis as a result of high doses of radiation 
(5,7,8,11).  Therefore, it is of high interest to investigate and evaluate the effects of soy 
isoflavones at an early time point after radiation and at a higher dose of radiation.   
     In the following experiment, esophageal tissue sections were evaluated at 1 week 
after radiation from mice receiving either 10 Gy or 25 Gy irradiation alone or 10 Gy / 25 
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Gy radiation in combination with soy isoflavones.  Untreated esophagi showed normal 
tissue layers at 1 week after radiation (Fig. 5A1, 5A2), and were comparable to 
esophagi analyzed in initial studies at later time points (Fig. 1C).  Esophagi from mice 
treated with soy isoflavones showed normal, undisturbed tissue layers, similar to control 
(Fig. 5B1, 5B2).  Esophagus tissue from mice treated with 10 Gy radiation or 25 Gy 
irradiation showed multiple alterations to the mucosal epithelium basal cell layer.  Basal 
cells showed morphological disruptions that were more pronounced in mice treated with 
25 Gy radiation.  Some basal cells appeared karyorrhexic with a fragmented nucleus 
(arrow in Fig. 5D1) and formed giant cells (arrows in Fig. 5D1,2).  Other basal cells 
appeared to have become hyperplastic, showing active mitosis in the mucosal 
epithelium (circles in Fig. 5C1, 5D1). Additionally, in esophagi from 10 Gy or 25 Gy 
radiation treatments, inner esophageal layers (IEL) showed increased thickening 
(bracket in 5C2) and disruptions in the continuity of mucosal basal cells (dotted lines in 
5C2).  Esophagi from mice treated with radiation and soy isoflavones showed limited 
karryorrhexic basal cells with no giant cells present, a reduced proportion of basal cells 
undergoing active proliferation, reduced thickening of IEL, and no disruption in the 
alignment of basal cells along the basement membrane (Fig. 5E1,2, 5F1,2). 
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CHAPTER 4:  DISCUSSION AND CONCLUSION 
     For NSCLC patients, radiation-induced esophagitis presents a major radiation dose-
limiting challenge to radiation oncologists and disrupts efficacy of radiation regimens (5). 
Multiple studies by Gomez et al. has associated radiation-induced esophagitis 
inflammatory cytokine profiles, inflammatory markers, chemoradiation-induced 
neutropenia, and gene polymorphisms as a result of inflammatory responses (19).  
Nearly all patients experience some level of esophageal toxicity within the field of their 
radiation treatment, and present with varying severity of odynophagia and dysphagia as 
a result of tissue injury and inflammation (7), necessitating the need for intervention and 
effective therapeutics. 
     Our lab has previously demonstrated the radioprotective effect of soy isoflavones in 
lung tumor bearing mice and in naïve bearing mice, mitigating radiation-induced 
pneumonitis and pulmonary fibrosis in normal lung tissue (2,3,4).  Based on these 
findings, the goals of my master’s research project were to identify and characterize the 
histopathological changes that occur in normal esophagus tissue in response to 
radiation injury, and to investigate the effect of soy isoflavones on reducing tissue 
damage in the esophagus.  These aims are based on the hypothesis that soy 
isoflavones may provide radioprotection of normal esophageal tissues from radiation-
induced tissue damage. 
     In order to assess histopathology of normal tissue, studies were performed in naïve, 
non-tumor bearing mice.  Mice were treated with a high dose of 10 Gy thoracic 
irradiation and an effective dose of soy isoflavones (1mg/day)(2,3,4), given prior and 
after radiation. In separate experiments, tissues were evaluated at 4, 10, and 16 weeks 
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after radiation to address late effects of radiation or at 1 week after radiation to address 
early effects of radiation.  
Soy isoflavones reduce esophageal tissue edema in response to radiation injury.  
     We have identified significant alterations in esophageal tissue layers caused by 
radiation injury.  In particular, thickening of the inner esophageal layers (IEL) was 
observed from 4 to 16 weeks after radiation.  These findings were also found already at 
1 week after radiation in separate experiments and could be the result of tissue edema. 
A hallmark of radiation-induced tissue damage in multiple organ systems includes tissue 
edema, or the subcompartmental accumulation of fluids, ultimately causing a swelling of 
one or more tissue compartments (20,21).  The edematous response of esophageal 
tissues is a highly documented phenomenon and esophageal swelling can be 
considered a contributor to dysphagia caused by radiation treatment (8,9,12). Our 
observation in irradiated mouse esophagus also reflected an edematous response.  
Interestingly, this thickening of IEL was significantly decreased by complementing 
radiation with soy isoflavones, suggesting that soy isoflavones influence one or many 
events associated with fluid accumulation from radiation-induced tissue damage.  
Soy isoflavones decrease collagen disintegration in lamina propria and limit 
collagen infiltration into muscularis mucosae.   
     Reduced density of Masson’s trichrome staining of collagen in lamina propria a 
different time points after radiation suggested that radiation causes collagen disruption 
and subsequent remodeling of the fibrous lamina propria compartment.  Additionally, 
radiation-induced tissue damage cause the infiltration of collagen fibers between 
hypertrophied smooth muscle cells in muscularis mucosae.  These effects are normal 
	  
	   	  
	  
17	  
responses to radiation-induced tissue injury, and were reduced when radiation 
treatment was combined with soy isoflavones.  Bentzen et al. describes the remodeling 
process a result of radiation tissue damage to include compartmentalized fibrosis (13). 
Fibrosis is a process to repair tissue damage and is a result of limited replenishment by 
existing stem cells.  This process involves a cytokine cascade that generates excessive 
collagen and extra cellular matrix deposition into sites of dead cells (12,13).  The 
process of fibrosis is necessary to maintain structural integrity, but at a serious cost as it 
replaces functional cells with non-functional tissue, therefore limiting the physiological 
capabilities of a damaged organ.  Fibrotic accumulation of collagen over long periods of 
time—months to years—can lead to esophageal stricture formation and can present as 
dysphagia, a chronic symptom from radiation (5,6,8,13).  Therefore, soy isoflavone 
supplementation to radiation therapy could be applied to reduce the progression of long-
term stricture formation as a result of radiation-induced fibrosis.    
Soy isoflavones mitigate radiation-induced smooth muscle cell hypertrophy in 
muscularis mucosae.  
     By immunohistochemical staining of smooth muscle cells within the muscularis 
mucosae, we observed changes caused by radiation, including increased cellular size, 
or hypertrophy, of smooth muscle cells with fragmentation in the continuity of smooth 
muscle layer.  This effect was seen as early as 1 week after radiation and persisted up 
to 16 weeks after radiation. However, smooth muscle cell disruption was reduced in 
tissues with combined treatment of radiation and soy isoflavones at all time points.  
Smooth muscle cell hypertrophy in response to radiation has been documented and 
observed in multiple organs containing smooth muscle (20,21). But specific studies 
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investigating the pathological events related to dysfunctional smooth muscle cells from 
radiation injury remain limited.  Preservation of smooth muscle cell structure by soy 
isoflavones, both at the cellular level by reducing hypertrophy, and at the tissue level by 
reducing fragmentation, could provide functional conservation of muscularis mucosae 
smooth muscle, limiting the development and progression of radiation-induced 
dysphagia. 
Soy isoflavones abrogate leukocyte infiltration at the edge of mucosal epithelium.  
     Assessment of radiation-induced damage to esophagus demonstrated significant 
infiltration of leukocytes in lamina propria at the edge of the mucosal epithelium, 
whereas tissue treated with radiation and soy isoflavones showed minimal presence of 
leukocytes.  Inflammatory infiltration is known to be a normal response by various 
tissues to radiation injury (12,13,22) and was reported to occur in our previous studies 
on radiation-induced toxicity to the lungs (2,3,4).  The initial insult of radiation initiates 
an inflammatory phase with chemokine and cytokine (TNF-α, IL-6, IL-1β) production to 
attract inflammatory cells to site of injury. This initial response occurs within hours and 
may extend over months (12,13,22) in conjunction with tissue edema, cellular swelling, 
lymphocytic infiltration, and apoptotic cell induction followed by tissue regeneration by 
stem cells (12).  Based on our findings that soy isoflavones mitigate the majority of 
these events, it is worth investigating if and how soy isoflavones may alter aspects of 
the immune system in the context of normal tissue inflammatory responses to radiation.   
     Additionally, it was reported by McBride et al. that radiation elicits a range of tissue 
responses that include a cytokine ‘breeze’, rather than cytokine storm (22).  It is shown 
that the strength of the inflammatory response is proportional to the intensity of radiation 
	  
	   	  
	  
19	  
treatment (22), and considering the radioprotective effects of soy isoflavones in limiting 
leukocyte infiltration shown in our data, future studies may want to evaluate the effects 
of soy isoflavones on inflammatory response at higher, clinically relevant, doses of 
radiation.  
Soy isoflavones limit the disruption of basal cell alignment and continuity.  
     The regular arrangement of basal cells depend on intracellular tight junctions, which 
hold cells together and are the basis for maintaining mucosal tissue barrier functions 
(23).  Radiation-induced tissue damage included disruption in the alignment of basal 
cells within mucosal epithelium, and this trend was seen at both early and late time 
points after radiation.  In esophagus tissues from mice treated with radiation and soy 
isoflavones, the disruption of basal cell alignment was diminished, and resembled the 
basal cell continuity found in control. A review examining the role of flavonoids in 
intestinal tight junction regulation showed that genistein, the primary isoflavone found in 
soy, protected intestinal tight junction barrier function by counteracting disassembly of 
occludins induced by oxidative stress and acetylaldehyde (24).  These findings could 
explain observations that soy isolfavones could reduce radiation-induced disruptions to 
mucosal basal cells in normal esophagus, providing maintenance of mucosal barrier 
function. 
Soy isoflavones reduce the number of radiation-induced abnormal basal cells.  
     The mucosal epithelial response to radiation injury included cellular changes in basal 
cells that were eliminated by combined radiation and soy isoflavone treatment. In 
response to radiation, some basal cells became karyorrhexic, where the nucleus 
becomes fragmented and precedes the potential cellular apoptosis induction. 
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Abnormally dividing basal cells form into giant cells that will ultimately die (12,13,22,28).  
Basal cells that have not undergone significant radiation damage, and subsequent 
induction of apoptotic cell death, will remain as actively dividing cells. As a function of 
actively replenishing the mucosal epithelium, these remaining basal cells may become 
hyperplastic in order to compensate for neighboring basal cells that have died and no 
longer contributed to replenishing mucosal epithelial cells. (12,25,28).  Drastic changes 
in basal cell morphology reflecting radiation damage were pronounced with a higher 
dose of 25 Gy irradiation, and were seen already at 1 week after radiation.  
     Soy isoflavones showed reduced presence of both karryorrhexic cells and actively 
dividing cells.  This effect was also observed with a higher dose of 25 Gy, confirming 
soy isoflavone’s radioprotective role in mucosal epithelium.  This could be explained by 
two previous studies identifying the role of genistein in reducing apoptosis induction in 
normal testicular mucosal tissues (28) and intestinal mucosal tissues (29).  Limiting the 
overwhelming induction of basal cell apoptosis in response to radiation by soy 
isoflavones could be of great benefit in maintaining the integrity of mucosal epithelium 
and reducing rapid and prolonged epithelial depletion implicated in radiation-induced 
odynophagia, and warrant further investigation.   
Summary and Conclusions 
     Taken together, these studies show that soy isoflavones provide a radioprotective 
role in numerous aspects of radiation-induced tissue damage and subsequent 
inflammatory responses.  Multiple radiation-induced histopathological alterations of the 
normal esophagus were identified, including tissue edema, collagen remodeling and 
disintegration, smooth muscle cell hypertrophy and fragmentation, inflammatory 
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leukocyte infiltration, and disruption to mucosal basal cell morphology and function.  By 
treating mice with combined therapy of radiation and soy isolfavones, esophageal 
tissues were comparable to that of control esophagi, showing limited tissue edema, 
dense collagen fibers that make up a thin lamina propria, reduced smooth muscle cell 
hypertrophy and continuous smooth muscle throughout the muscularis mucosae, 
minimal inflammatory leukocyte infiltration at the edge of the mucosal epithelium, and 
maintenance of alignment with decreased numbers of both karryorrhexic and 
hyperplastic mucosal basal cells.  While many of these changes are mediated by an 
inflammatory response that varies from patient to patient upon radiation injury, nearly all 
patients receiving thoracic radiation experience some level of radiation-induced 
esophagitis.  These findings can translate into the potential application of soy isoflavone 
supplementation during radiation therapy with the goal to mitigate the harmful side 
effects of radiation-induced tissue damage to normal esophagus.  Further investigation 
of the various radioprotective properties of soy isoflavones in preserving normal 
esophagus tissue and organ function is warranted. 
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CHAPTER 5:  FIGURES, TABLES, AND LEGENDS 
 
 
FIGURE 1. H&E staining of esophagus tissue sections treated with soy, radiation, and radiation + 
soy.   Esophagi tissue sections were obtained from control mice and mice treated with soy or radiation 
(Rad) or radiation + soy (Soy + Rad) at 4, 10, and 16 weeks after radiation.  Sections were stained with 
H&E.  (A). Transverse tissue section of the esophagus at low magnification [10x].  (B). Esophageal tissue 
layers include the mucosal epithelium (EPI), lamina propria (LP), muscularis mucosae (MM), submucosa 
(SM) lining the muscularis externa (ME) [x100].  Because alterations induced by radiation were observed 
in LP, MM, and SM, these three layers were grouped as inner esophageal layer (IEL).  (C). Sections from 
control mice showing normal morphology of the different tissue layers.  (D). Sections from mice treated 
with soy are showing mild changes in IEL and EPI.  (E). Sections from mice treated with radiation 
showing alterations in the EPI with disruptions in the alignment of epithelial cells in the basal cell layer 
(circle in E.1).  In the MM layer, consisting of smooth muscle cells, hypertrophy and cytoplasmic 
vacuolation were observed (arrows in E.2).  Overall thickening of IEL and extensive vacuolation were 
observed at 4, 10, and 16 weeks after radiation (brackets in E.3).  (F)  Sections from mice treated with 
radiation + soy showing less alterations than in radiation alone, mostly in LP and MM layers. [All 
magnifications x100].     
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Treatment Inner Esophageal Layer Thickness (Mean µm ± SEM) 
 Day 28 Day 70 Day 112 
Control 15.77 ± 0.40 22.74 ± 0.58* 25.13 ± 0.54 
Soy alone 20.58 ± 0.59 21.80 ± 0.64* 30.24 ± 1.08** 
RT alone 30.66 ± 0.67 41.54 ± 1.18 40.43 ± 0.91 
RT+Soy 25.54 ± 0.67 27.03 ± 0.74 33.28 ± 0.80** 
 
 
TABLE 2. Morphometric measurements of inner esophageal tissue layers.  Using Image Pro Plus 
software analysis of H&E slides, the thickness of the IEL was quantified in 5 fields of 100x for each 
mouse esophagus.  Data computer on mouse esophagus was from 4 representative mice from  2 
separate experiments, yielding 100 measurements per treatment.  Student’s T-test revealed significant 
differences between all treatment groups except those denoted by * and **.  
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FIGURE 2. Effect of soy and radiation on fibrotic connective tissue layers of esophagus.  
Esophagus tissue sections obtained from the experiments described in figure 1 were stained with 
Masson’s Trichrome for detection of collagen fibers within the LP and SM connective tissues. (A) 
Sections from control mice showed normal, dense and well organized layers of collagen fibers within the 
LP at all time points [x100].  (B) Sections from mice treated with soy showed LP and SM fibrous layers 
similar to that of control.  (C) Sections from mice treated with radiation showed alterations in LP and SM 
with disruptions in the integrity of connective collagen fibers including thickening of LP and decreased 
density of collagen fibers as well as focal infiltration of fibers around smooth muscle cells within the MM.  
(D) Sections from mice treated with radiation + soy showed reduced collagen infiltration into MM smooth 
muscle compared to radiation and a higher density of fibers that is comparable to LP of control and soy-
treated esophagus. [All magnifications x100].  
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FIGURE 3. Effect of soy and radiation on smooth muscle cells in muscularis mucosae and 
epithelial layer of esophagus.  Esophagus tissue sections obtained from the experiments described in 
figure 1 were stained with anti-αSMA by IHC for detection of smooth muscle cells in MM.  (A) Sections 
from control mice showed normal thin MM layer with dense staining of smooth muscle cells separating 
the LP and SM.  (B) Sections from mice treated with soy showed normal MM similar to control.  (C) 
Radiation caused obvious thickening of LP and MM seen by MT.  Smooth muscle cell hypertrophy (circles 
in C.1), large empty vacuoles, and both rounding up and condensation of smooth muscle cell nuclei were 
evident in MM.  Interruptions in the integrity of MM layer were also observed (arrows in C.2).  (D) Sections 
from mice treated with radiation + soy showed reduced smooth muscle cell hypertrophy and limited 
disintegration of MM compared to radiation alone. [All magnifications x100]. 
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Fibrosis Collagen 
Density 
  
Smooth Muscle Cell  
Hypertrophy 
  
(Masson Trichrome - 
Lamina Propria) 
  
(α-SMA - Muscularis Mucosa) 
  
 
D28 D70 D112   
 
D28 D70 D112 
Control 
 
++ ++ ++   ± ± ± 
Soy 
 
++ ++ ++ 
  
± ± + 
Radiation 
 
+ + + 
  
++ +++ +++ 
Rad + 
Soy 
 
++ ++ ++   
 
± + ++ 
 
Table 3. Summary and Quantification of Histological Observations.   Histological findings from 
experiments presented in Figures 2 and 3 were quantified.  The extent of fibrosis (collagen density) and 
MM damage (smooth muscle cell hypertrophy) were scaled from weak (±), moderate (+), strong (++), to 
heavy (+++).   
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FIGURE 4. Leukocyte infiltration in esophageal tissues treated with soy and radiation.  Esophagi 
tissue sections were obtained from control mice and mice treated with soy or radiation (Rad) or radiation 
+ soy (Soy + Rad) at 4 weeks after radiation.  Esophagus tissues were stained with anti-CD45 by IHC for 
detection of leukocytes at the border between LP and EPI.  (A) Sections from control mice showed no 
staining of CD45+ cells within the LP nor EPI tissue layers, and (B) similar results were shown in mice 
treated with soy.  (C) Sections from mice treated with radiation showed focal CD45+ leukocyte infiltration 
in LP and forming clusters at the edge of EPI basal layer (arrows in C).  (D) Sections from mice treated 
with radiation + soy showed minimal CD45+ cell infiltrates comparable to control and soy-treated 
esophagus. [All magnifications x100].  
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FIGURE 5.  Early effects of soy on esophageal tissues treated with 25 Gy radiation compared to 10 
Gy radiation.  Esophagi tissue sections were obtained from control mice and mice treated with soy or 
radiation (Rad) or radiation + soy (Soy + Rad) at 1 week after a radiation dose of 10Gy or 25Gy.  Sections 
were stained with H&E and each treatment includes two representative images.  (A) Sections from control 
mice show healthy esophagus tissue layers, including normal mucosal epithelium, including normal basal 
cell shape, size and morphology.  (B) Sections from mice treated with soy showed normal mucosal 
epithelium comparable to control mice.  (C) Sections from mice treated with 10Gy radiation showed 
several changes in the mucosal epithelium, and (D) a higher dose of 25Gy radiation caused greater 
alterations in the EPI mucosal layer, including basal cell hyperplasia showing increased mitosis (circles in 
C.1 and D.1), karyorrhexic basal cells and formation into giant cells (arrows in D.1 and D.2), and 
disruptions to basal cell basement membrane continuity (dotted lines in C.2).  Additionally, tissue sections 
showed large regions of increased thickness of IEL, including LP and MM (brackets in C.2).  (E, F) 
Sections from mice receiving combined treatment of 10Gy or 25Gy radiation with soy showed decreased 
alterations in mucosal basal cell morphology, including reduced basal cell hyperplasia, few to no giant cell 
formation, and fewer regions of disrupted basal cell basement membrane continuity, similar to control and 
soy treated mice.  Additionally, sections from mice having soy treatment with both radiation doses 
showed decreased thickening of the IEL.   
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ABSTRACT 
RADIATION-INDCUED ESOPHAGITIS IS MITIGATED BY SOY ISOFLAVONES 
by 
MATTHEW D. FOUNTAIN 
May 2015 
Advisor: Dr. Gilda G. Hillman 
Major: Immunology/Microbiology 
Degree: Masters of Science 
     Lung cancer patients receiving radiotherapy present with acute and chronic 
esophagitis, resulting in pain and difficulties swallowing.  These effects are due to 
radiation injury to the normal tissues in the esophagus.  Our previous studies in pre-
clinical models of lung cancer and naïve mice have shown that soy isoflavones 
alleviates radiation-induced toxicity to normal lung, including a decrease in pneumonitis 
and fibrosis.  In this study, we have investigated whether radiation-induced esophagitis 
can be reduced by soy isoflavones.  C57BL/6 mice were treated with 10 Gy or 25 Gy for 
thoracic irradiation and soy isoflavones given daily at 1mg/mouse up to 16 weeks.  
Esophagi were resected at various time points (1,4,10,16 weeks post-radiation).  
Damage to esophageal tissues was assessed by H&E staining and Masson’s 
Trichrome.  The effects on smooth muscle cells and leukocyte infiltration were 
determined by immunohistochemistry using anti-aSMA and anti-CD45.  Histological 
analysis revealed esophagus tissue edema and inflammatory leukocyte infiltration.  
Specific findings included alterations in the mucosal epithelium, connective tissue 
disruption in the lamina propria, and smooth muscle cell hypertrophy in the muscularis 
mucosa.  Radiation-induced tissue injuries were reduced by combining soy isoflavones 
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with radiation treatments.  Quantitative evaluation of thickened, edematous tissue layers 
was performed by morphometric measurements.  Analysis of 100 measurements per 
treatment group revealed a significant decrease in the thickness of esophageal layers in 
irradiated mice treated with soy (25.54um±0.67SEM) to radiation alone 
(30.66um±0.67SEM) (p<0.0001).  Radiation-induced damage presented within 1 week 
and progressively worsened with time, being more pronounced with 25 Gy compared to 
10 Gy, but was also decreased by soy supplementation.  Thoracic irradiation caused 
injury to multiple layers of the esophagus, and these effects were mitigated by soy 
isoflavones.  These findings suggest that soy isoflavones have a radioprotective effect 
on the esophagus, mitigating the early and late effects seen in radiation-induced 
esophagitis.  
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